104 related articles for article (PubMed ID: 27396228)
1. The Outcome of Radiofrequency Ablation of Metastatic Liver Tumors.
Thamtorawat S; Rojwatcharapibarn S; Tongdee T; Siriapisith T
J Med Assoc Thai; 2016 Apr; 99(4):424-32. PubMed ID: 27396228
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency Ablation of Lung Metastasis Not Suitable for Surgery: Experience in Siriraj Hospital.
Tongdee T; Tantigate P; Tongdee R
J Med Assoc Thai; 2015 Oct; 98(10):1019-27. PubMed ID: 26638594
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
5. Incidence of complication and tumor recurrence after radiofrequency ablation in high-risk location of hepatocellular carcinoma patients.
Thamtorawat S; Limsuwarn P; Tongdee T; Chaiyasoot W; Siriapisith T
J Med Assoc Thai; 2014 Jan; 97(1):95-100. PubMed ID: 24701735
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence.
Ayav A; Germain A; Marchal F; Tierris I; Laurent V; Bazin C; Yuan Y; Robert L; Brunaud L; Bresler L
Am J Surg; 2010 Oct; 200(4):435-9. PubMed ID: 20409524
[TBL] [Abstract][Full Text] [Related]
9. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
11. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
13. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
19. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
